| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1100744905 |
| P356 | DOI | 10.1007/S11916-018-0658-8 |
| P698 | PubMed publication ID | 29388063 |
| P2093 | author name string | Mark Wallace | |
| Tim Furnish | |||
| Brittany Grovey | |||
| Gemayel Lee | |||
| P2860 | cites work | Neuropathic pain is associated with increased nodal persistent Na(+) currents in human diabetic neuropathy | Q48828917 |
| The burden of neuropathic pain: results from a cross-sectional survey. | Q51830808 | ||
| Sensory afferent impulses originate from dorsal root ganglia as well as from the periphery in normal and nerve injured rats. | Q51850252 | ||
| Sensitization to heat through G-protein-coupled receptor pathways in the isolated sciatic mouse nerve | Q60678454 | ||
| Structural basis of sympathetic-sensory coupling in rat and human dorsal root ganglia following peripheral nerve injury | Q73907902 | ||
| Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion? | Q80744903 | ||
| Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain | Q24634161 | ||
| Adverse effects of medical cannabinoids: a systematic review | Q24644380 | ||
| Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials | Q26778552 | ||
| Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data | Q28084769 | ||
| Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis | Q28085455 | ||
| Molecular characterization of a peripheral receptor for cannabinoids | Q28298338 | ||
| Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 | ||
| Determination and characterization of a cannabinoid receptor in rat brain | Q29618888 | ||
| Randomized placebo-controlled double-blind clinical trial of cannabis-based medicinal product (Sativex) in painful diabetic neuropathy: depression is a major confounding factor | Q33556725 | ||
| A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms | Q33964712 | ||
| Biology of endocannabinoid synthesis system | Q34015534 | ||
| The endocannabinoid system as a target for the treatment of neurodegenerative disease | Q34098196 | ||
| Smoked cannabis for chronic neuropathic pain: a randomized controlled trial | Q34134958 | ||
| Central modulation of pain | Q34245455 | ||
| Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. | Q34266560 | ||
| History of cannabis as a medicine: a review | Q34543279 | ||
| Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis | Q34561157 | ||
| Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial | Q34575407 | ||
| Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial | Q34585310 | ||
| Vaporization as a smokeless cannabis delivery system: a pilot study | Q34618398 | ||
| Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers. | Q34724243 | ||
| Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial | Q34731928 | ||
| The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs | Q34992627 | ||
| Burden of illness associated with peripheral and central neuropathic pain among adults seeking treatment in the United States: a patient-centered evaluation | Q35209363 | ||
| Pain severity and the economic burden of neuropathic pain in the United States: BEAT Neuropathic Pain Observational Study | Q35402169 | ||
| Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. | Q35678770 | ||
| Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat. | Q35688088 | ||
| Nerve injury-induced calcium channel alpha-2-delta-1 protein dysregulation leads to increased pre-synaptic excitatory input into deep dorsal horn neurons and neuropathic allodynia | Q35963412 | ||
| Role of cation-chloride-cotransporters (CCC) in pain and hyperalgesia | Q36196689 | ||
| Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors | Q36447081 | ||
| Low-dose vaporized cannabis significantly improves neuropathic pain | Q36593518 | ||
| Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain | Q36997712 | ||
| A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain | Q37141496 | ||
| Association between marijuana exposure and pulmonary function over 20 years | Q37343800 | ||
| Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy. | Q37495207 | ||
| Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy. | Q37512670 | ||
| The role of glia and the immune system in the development and maintenance of neuropathic pain | Q37729355 | ||
| Potassium channels as a potential therapeutic target for trigeminal neuropathic and inflammatory pain. | Q37827198 | ||
| Involvement of the opioid and cannabinoid systems in pain control: new insights from knockout studies | Q38092478 | ||
| Neuropathic pain in the general population: a systematic review of epidemiological studies. | Q38167585 | ||
| Cannabinoids for neuropathic pain | Q38243708 | ||
| Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons. | Q38322450 | ||
| Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence | Q38577921 | ||
| The endocannabinoid system and neuropathic pain | Q38702807 | ||
| An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease | Q38855100 | ||
| Involvement of mesolimbic dopaminergic network in neuropathic pain relief by treadmill exercise: A study for specific neural control with Gi-DREADD in mice | Q39163213 | ||
| A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis. | Q39237599 | ||
| Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial | Q39327817 | ||
| Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial | Q39373693 | ||
| Long-term cannabis use: characteristics of users in an Australian rural area | Q39444899 | ||
| Ephaptic transmission in chronically damaged peripheral nerves | Q40247414 | ||
| Increased peripheral nerve excitability and local NaV1.8 mRNA up-regulation in painful neuropathy. | Q41899981 | ||
| Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles | Q42327992 | ||
| Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system | Q43678414 | ||
| Medium and large injured dorsal root ganglion cells increase TRPV-1, accompanied by increased alpha2C-adrenoceptor co-expression and functional inhibition by clonidine | Q45231665 | ||
| Cannabis in Pain Treatment: Clinical and Research Considerations. | Q45998776 | ||
| Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission | Q46146049 | ||
| Medicinal Marijuana: Here to Stay and Time to Take Responsibility | Q46694646 | ||
| Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract | Q46819181 | ||
| CB1 receptors modulate affective behaviour induced by neuropathic pain | Q47718038 | ||
| A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain | Q48026611 | ||
| A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment | Q48131842 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | medical cannabis | Q1033379 |
| neuropathic pain | Q2798704 | ||
| P304 | page(s) | 8 | |
| P577 | publication date | 2018-02-01 | |
| P1433 | published in | Current Pain and Headache Reports | Q15761579 |
| P1476 | title | Medical Cannabis for Neuropathic Pain | |
| P478 | volume | 22 |
Search more.